TIS 0.00% 0.0¢ tissue therapies limited

What is going on, page-19

  1. 2,617 Posts.
    lightbulb Created with Sketch. 4
    I find it interesting and of considerable value that the health economics case includes the pain amelioration effect of using VitroGro. A considerable part of the cost of treating ulcers in the conventional manner is associated with pain management. I suspect our heath economics case will be irresistible for medical insurance rebate.
    DYOR
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.